within Pharmacolibrary.Drugs.ATC.D;

model D06AX02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00029666666666666665,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D06AX02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Chloramphenicol is a broad-spectrum antibiotic effective against a variety of Gram-positive and Gram-negative bacteria. It is used for the treatment of serious infections such as typhoid fever, meningitis, and rickettsial diseases, but its use has declined due to serious adverse effects (notably aplastic anemia). It is not a first-line antibiotic in most countries today and is restricted for specific indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after oral and intravenous administration.</p><h4>References</h4><ol><li><p>Nahata, MC, &amp; Powell, DA (1983). Comparative bioavailability and pharmacokinetics of chloramphenicol after intravenous chloramphenicol succinate in premature infants and older patients. <i>Developmental pharmacology and therapeutics</i> 6(1) 23–32. DOI:<a href=\"https://doi.org/10.1159/000457274\">10.1159/000457274</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6839912/\">https://pubmed.ncbi.nlm.nih.gov/6839912</a></p></li><li><p>Sullins, AK, &amp; Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. <i>Paediatric drugs</i> 15(2) 93–117. DOI:<a href=\"https://doi.org/10.1007/s40272-013-0017-5\">10.1007/s40272-013-0017-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23529866/\">https://pubmed.ncbi.nlm.nih.gov/23529866</a></p></li><li><p>Ambrose, PJ (1984). Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate. <i>Clinical pharmacokinetics</i> 9(3) 222–238. DOI:<a href=\"https://doi.org/10.2165/00003088-198409030-00004\">10.2165/00003088-198409030-00004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6375931/\">https://pubmed.ncbi.nlm.nih.gov/6375931</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D06AX02;
